Fenofibrate for Patients With COVID-19 Requiring Hospitalization

Conditions:   Corona Virus Disease (COVID-19);   Respiratory Distress Syndrome;   SARS-CoV-2 Infection Interventions:   Drug: TriCor® 145mg tablets;   Other: Usual Care;   Other: Placebo Sponsors:   Hebrew University of Jerusalem;   Barzilai Medical Center Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials